Analytical Data
-
Gene name
CSPG5
- Application
-
Alternative Names
NGC; CALEB; Acidic leucine-rich EGF-like domain-containing brain protein; Neuroglycan C
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9ERQ6
-
Expression Region
Ala139~Arg370
-
Molecular Weight
41kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CSPG5, or Chondroitin Sulfate Proteoglycan 5, is a member of the chondroitin sulfate proteoglycan family, which plays crucial roles in cell signaling, tissue development, and the modulation of the extracellular matrix. CSPG5 is primarily expressed in the brain and has been implicated in various neurological conditions, as well as in the regulation of cell behavior during development and injury response. Research into CSPG5 has gained momentum due to its involvement in processes such as neuroinflammation, which contributes to conditions like Alzheimer's disease and multiple sclerosis. Moreover, CSPG5 has been suggested to influence tumor progression and metastasis in certain cancers. The recombinant protein form of CSPG5 allows for detailed studies of its structure-function relationships, interactions with other biomolecules, and its potential therapeutic applications. Investigating CSPG5 at the molecular level can provide insights into its precise role in cellular mechanisms and may unveil novel strategies for treating neurological disorders and cancer. Thus, producing CSPG5 as a recombinant protein is crucial for advancing our understanding of its biology and exploring its potential as a biomarker or therapeutic target in various diseases.
